Acurx Pharmaceuticals Inc (NASDAQ: ACXP) on Monday, soared 9.55%% from the previous trading day, before settling in for the closing price of $0.55. Within the past 52 weeks, ACXP’s price has moved between $0.30 and $3.33.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -7.84% over the past five years. The company achieved an average annual earnings per share of 42.53%. With a float of $20.39 million, this company’s outstanding shares have now reached $22.40 million.
Let’s look at the performance matrix of the company that is accounted for 4 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Acurx Pharmaceuticals Inc (ACXP) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Acurx Pharmaceuticals Inc is 13.17%, while institutional ownership is 14.90%. The most recent insider transaction that took place on Jan 06 ’25, was worth 25,000. In this transaction Director of this company bought 24,631 shares at a rate of $1.01, taking the stock ownership to the 27,708 shares. Before that another transaction happened on Jan 06 ’25, when Company’s Director bought 24,631 for $1.01, making the entire transaction worth $25,000. This insider now owns 137,183 shares in total.
Acurx Pharmaceuticals Inc (ACXP) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 42.53% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.59% during the next five years compared to -7.84% drop over the previous five years of trading.
Acurx Pharmaceuticals Inc (NASDAQ: ACXP) Trading Performance Indicators
Acurx Pharmaceuticals Inc (ACXP) is currently performing well based on its current performance indicators. A quick ratio of 1.93 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.70, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.51 in one year’s time.
Technical Analysis of Acurx Pharmaceuticals Inc (ACXP)
Acurx Pharmaceuticals Inc (NASDAQ: ACXP) saw its 5-day average volume 72.47 million, a positive change from its year-to-date volume of 3.37 million. As of the previous 9 days, the stock’s Stochastic %D was 43.22%.
During the past 100 days, Acurx Pharmaceuticals Inc’s (ACXP) raw stochastic average was set at 40.33%, which indicates a significant increase from 40.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 438.33% in the past 14 days, which was higher than the 188.53% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4001, while its 200-day Moving Average is $0.9842. Nevertheless, the first resistance level for the watch stands at $0.6499 in the near term. At $0.6974, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.7627. If the price goes on to break the first support level at $0.5371, it is likely to go to the next support level at $0.4718. Assuming the price breaks the second support level, the third support level stands at $0.4243.
Acurx Pharmaceuticals Inc (NASDAQ: ACXP) Key Stats
Market capitalization of the company is 14.14 million based on 23,482K outstanding shares. Right now, sales total 0 K and income totals -14,100 K. The company made 0 K in profit during its latest quarter, and -2,150 K in sales during its previous quarter.
